zhejiang d.a. diagnostics-a
(300244:Shenzhen Stock Exchange)
zhejiang d.a. diagnostics-a (300244) Snapshot
|
Open
--
|
Previous Close
--
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
-- - --
|
52 Week Low
-- - --
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
zhejiang d.a. diagnostics-a (300244) Related Businessweek News
No Related Businessweek News Foundzhejiang d.a. diagnostics-a (300244) Details
Zhejiang Di'an Diagnostic Technology Co., Ltd. provides third party outsourcing medical diagnostic services. It engages in the identification, diagnostic product sale, and research and development of diagnostic techniques and other fields. The company offers a range of products covering clinical diagnosis, molecular pathology diagnostics, bioinformatics, pharmaceutical research, and other professional applications; and professional products, such as instruments, reagents, consumables, software, and technical services to various levels of hospitals, research institutes, and medical laboratories. It also supplies medical and clinical laboratory instrumentation and ancillary reagents. The company was founded in 2001 and is based in Hangzhou, China.
zhejiang d.a. diagnostics-a (300244) Key Developments
Zhejiang Di'an Diagnostic Technology Co., Ltd. announced that at the annual general meeting held on May 2, 2013, the shareholders approved amendments to the company's articles of association.
Zhejiang Di'an Diagnostic Technology Co., Ltd. announced that they will report Q1, 2013 results on Apr 19, 2013
Zhejiang Di'an Diagnostic Technology Co., Ltd. proposed to its Annual General Meeting to be held on May 2, 2013, to consider and approve the cash dividend (tax included) of CNY 1.00000000 per 10 shares. At meeting, the shareholders also consider and approve the proposed amendments to the company's articles of association.
| Recently Viewed | |||
| 300244:CH | CNY43.52 CNY | +2.52 | |
| Company | Last | Change | |
| No competitor information is available for 300244. | |||
| View Industry Companies | |||
Industry Analysis
300244
Industry Average
| Valuation | 300244 | Industry Range |
| Price/Earnings | 63.2x |
|
| Price/Sales | 5.2x |
|
| Price/Book | 7.6x |
|
| Price/Cash Flow | 63.7x |
|
| TEV/Sales | 4.8x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact ZHEJIANG D.A. DIAGNOSTICS-A, please visit www.dagene.net. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








